Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 5 (2008), Issue 6 (June)

1. Brief motivational interviewing for teens at risk of substance use consequences: a randomized pilot study in a primary care clinic.
   J Subst Abuse Treat, 35(1): 53-61. [Abstract] [Full-text]
2. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.
   J Pain, 9(6): 506-21. [Abstract] [Full-text]
3. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.
   J Biol Chem, 283(23): 16124-34. [Abstract] [Full-text]
4. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics.
   Neuroimage, 41(3): 1067-74. [Abstract] [Full-text]
5. Association of cannabis use with prodromal symptoms of psychosis in adolescence.
   Br J Psychiatry, 192(6): 470-1. [Abstract] [Full-text]
6. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project.
   Arch Gen Psychiatry, 65(6): 713-21. [Abstract] [Full-text]
7. Regional brain abnormalities associated with long-term heavy cannabis use.
   Arch Gen Psychiatry, 65(6): 694-701. [Abstract] [Full-text]
8. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood.
   Arch Gen Psychiatry, 65(6): 674-82. [Abstract] [Full-text]
9. The effects of hemicelluloses and lignin removal on water uptake behavior of hemp fibers.
   Bioresour Technol, 99(15): 7152-9. [Abstract] [Full-text]
10. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities.
    BMC Public Health, 8: 155. [Abstract] [Full-text]
11. Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia.
    Aust N Z J Obstet Gynaecol, 48(3): 248-54. [Abstract] [Full-text]
12. Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis.
    Neurosci Lett, 439(1): 106-10. [Abstract] [Full-text]
13. The At-risk Adolescent Marijuana Nonuser: Expanding the Standard Distinction.
    Prev Sci, 9(2): 129-37. [Abstract] [Full-text]
14. What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention.
    Int J Methods Psychiatr Res, 17: S16-S29. [Abstract] [Full-text]
15. Associations of substance use problems with intimate partner violence for at-risk men in long-term relationships.
    J Fam Psychol, 22(3): 429-38. [Abstract] [Full-text]
16. Latent growth modeling of the relationship between depressive symptoms and substance use during adolescence.
    Psychol Addict Behav, 22(2): 186-97. [Abstract] [Full-text]
17. Cannabis: a trigger for acute myocardial infarction? A case report.
    J Cardiovasc Med (Hagerstown), 9(7): 725-8. [Abstract] [Full-text]
18. Prevalence of recent illicit substance use and reporting bias among MSM and other urban males.
    Addict Behav, 33(8): 1055-60. [Abstract] [Full-text]
19. Cyclic vomiting and compulsive bathing with chronic cannabis abuse.
    Clin Gastroenterol Hepatol, 6(6): 710-2. [Abstract] [Full-text]
20. Characteristics of youths with hearing loss admitted to substance abuse treatment.
    J Deaf Stud Deaf Educ, 13(3): 336-50. [Abstract] [Full-text]
21. Social capital, political trust and experience of cannabis smoking: A population-based study in southern Sweden.
    Prev Med, 46(6): 599-604. [Abstract] [Full-text]
22. Disordered eating and substance use in high-school students: results from the Youth Risk Behavior Surveillance System.
    Int J Eat Disord, 41(5): 464-70. [Abstract] [Full-text]
23. Are there genetic influences on addiction: evidence from family, adoption and twin studies.
    Addiction, 103(7): 1069-81. [Abstract] [Full-text]
24. Effects of behavioral intervention on substance use among people living with HIV: the Healthy Living Project randomized controlled study.
    Addiction, 103(7): 1206-14. [Abstract] [Full-text]
25. Cannabis potency and contamination: a review of the literature.
    Addiction, 103(7): 1100-9. [Abstract] [Full-text]
26. Assessment of forebrain-dependent trace eyeblink conditioning in chronic cannabis users.
    Neurosci Lett, 439(3): 264-8. [Abstract] [Full-text]
27. Therapeutic potential of cannabis in pain medicine.
    Br J Anaesth, 101(1): 59-68. [Abstract] [Full-text]
28. Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users.
    Drug Alcohol Depend, 96(3): 193-201. [Abstract] [Full-text]
29. Adverse effects of medical cannabinoids: a systematic review.
    CMAJ, 178(13): 1669-78. [Abstract] [Full-text]
30. Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
    Arch Pharm Res, 31(6): 805-813. [Abstract] [Full-text]
31. Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin users.
    AIDS Behav, 12(4): 662-9. [Abstract] [Full-text]
32. Health access and status of adolescents and young adults using youth employment and training programs in an urban environment.
    J Adolesc Health, 43(1): 30-7. [Abstract] [Full-text]
33. Schizophrenia: from developmental deviance to dopamine dysregulation.
    Eur Neuropsychopharmacol, 18: S129-34. [Abstract] [Full-text]
34. Prenatal cocaine exposure: drug and environmental effects at 9 years.
    J Pediatr, 153(1): 105-11. [Abstract] [Full-text]
35. Characterizing adolescent prescription misusers: a population-based study.
    J Am Acad Child Adolesc Psychiatry, 47(7): 745-54. [Abstract] [Full-text]
36. Schizophrenia, "Just the Facts" What we know in 2008. 2. Epidemiology and etiology.
    Schizophr Res, 102(1): 1-18. [Abstract] [Full-text]
37. Executive function deficits in short-term abstinent cannabis users.
    Hum Psychopharmacol, 23(5): 409-15. [Abstract] [Full-text]
38. How high: Quantity as a predictor of cannabis-related problems.
    Harm Reduct J, 5: 20. [Abstract] [Full-text]
39. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
    Anesthesiology, 109(1): 101-10. [Abstract] [Full-text]
40. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders.
    Nicotine Tob Res, 10(6): 969-74. [Abstract] [Full-text]
41. A cross-sectional survey of young people attending a music festival: associations between drug use and musical preference.
    Drug Alcohol Rev, 27(4): 439-41. [Abstract] [Full-text]
42. Promising performance of a juvenile justice diversion programme in remote Aboriginal communities, Northern Territory, Australia.
    Drug Alcohol Rev, 27(4): 433-8. [Abstract] [Full-text]
43. How to Screen for Problematic Cannabis Use in Population Surveys. An Evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss Sample of Adolescents and Young Adults.
    Eur Addict Res, 14(4): 190-197. [Abstract] [Full-text]
44. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.
    Br J Pharmacol, 154(5): 1001-8. [Abstract] [Full-text]
45. Application of two-dimensional gas chromatography combined with pixel-based chemometric processing for the chemical profiling of illicit drug samples.
    J Chromatogr A, 1200(1): 8-16. [Abstract] [Full-text]
46. Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers.
    Eur Neuropsychopharmacol, 18(8): 612-9. [Abstract] [Full-text]
47. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Eur Neuropsychopharmacol, 18(8): 569-77. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.